Apelin-13 drives VSMC proliferation and atherosclerosis through REEP5-dependent disruption of ER-mitochondria coupling and glycolytic shift
Life Sciences · 2026
DOI: 10.1016/j.lfs.2026.124643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026. Verfasst von Huimei Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy and Pharmacology, College of Basic Medical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China. Hauptthemen laut MEDLINE: Atherosclerosis, Intercellular Signaling Peptides and Proteins, Muscle, Smooth, Vascular, Mitochondria. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Hunan Provincial Innovation Foundation for Postgraduate, Key Project of Research and Development Plan of Hunan Province, Hunan Provincial Natural Science Foundation.
Abstract (Originalsprache)
Atherosclerosis is characterized by pathological vascular smooth muscle cell (VSMC) proliferation and metabolic dysregulation, yet the underlying mechanisms remain incompletely understood. Here, we identified receptor expression enhancer protein 5 (REEP5) as a potential regulator of VSMC proliferation in atherosclerosis by analyzing single-cell RNA sequencing datasets from human atherosclerotic coronary arteries and aortic tissues. REEP5 expression was markedly reduced in proliferative SMCs. In human aortic VSMCs, apelin-13 downregulated REEP5 in a time- and concentration-dependent manner. The REEP5 downregulation was associated with disrupted endoplasmic reticulum architecture, increased endoplasmic reticulum vacuolization, and impaired mitochondria-associated membrane coupling. Moreover, apelin-13 elevated mitochondrial reactive oxygen species, reduced mitochondrial membrane potential, and decreased mitochondrial Ca2+ levels, indicating mitochondrial dysfunction. Functionally, apelin-13 promoted a metabolic shift toward glycolysis, as evidenced by increased glucose consumption, lactate production, glycolytic enzyme expression and activity, and extracellular acidification rate, together with reduced oxidative phosphorylation and decreased oxygen consumption rate in vitro. REEP5 overexpression largely reversed these alterations and inhibited apelin-13-induced VSMC proliferation. Inhibition of glycolysis similarly attenuated the pro-proliferative effect of apelin-13. In ApoE-/- mice, REEP5 overexpression alleviated apelin-13-induced exacerbation of atherosclerosis, reduced lesion burden, ameliorated dyslipidemia, and reduced glycolytic marker expression in plaques. Collectively, these findings suggested that apelin-13 may promote VSMC proliferation and atherosclerotic progression, at least in part, by downregulating REEP5 and disrupting mitochondria-associated membrane coupling, thereby contributing to a glycolytic metabolic shift in VSMCs. Targeting the REEP5/mitochondria-associated membrane coupling axis may be a potential therapeutic target for atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacy and Pharmacology, College of Basic Medical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China.
- Department of Anesthesiology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, China.
- Institute of Pharmacy and Pharmacology, College of Basic Medical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China. Electronic address: 1995001765@usc.edu.cn.
- Institute of Pharmacy and Pharmacology, College of Basic Medical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China. Electronic address: 2005001782@usc.edu.cn.
Förderung
- Hunan Provincial Innovation Foundation for Postgraduate
- Key Project of Research and Development Plan of Hunan Province
- Hunan Provincial Natural Science Foundation
Zitieren
APA
Liu, H., Chen, W., Mao, H., Lu, R., Zhou, X., Ouyang, X., Fan, S., Huang, X., Hu, X., Deng, Y., Chen, L., & Li, L. (2026). Apelin-13 drives VSMC proliferation and atherosclerosis through REEP5-dependent disruption of ER-mitochondria coupling and glycolytic shift. Life Sciences. https://doi.org/10.1016/j.lfs.2026.124643
Vancouver
Liu H, Chen W, Mao H, Lu R, Zhou X, Ouyang X, et al. Apelin-13 drives VSMC proliferation and atherosclerosis through REEP5-dependent disruption of ER-mitochondria coupling and glycolytic shift. Life Sciences. 2026. doi:10.1016/j.lfs.2026.124643
BibTeX
@article{Liu2026,
author = {Liu, Huimei and Chen, Wei and Mao, Hui and Lu, Ruirui and Zhou, Xiaosi and Ouyang, Xueqian and Fan, Sisi and Huang, Xiaohui and Hu, Xiaobo and Deng, Yixuan and Chen, Linxi and Li, Lanfang},
title = {Apelin-13 drives VSMC proliferation and atherosclerosis through REEP5-dependent disruption of ER-mitochondria coupling and glycolytic shift},
journal = {Life Sciences},
year = {2026},
doi = {10.1016/j.lfs.2026.124643}
}
EUVIMED